HonorStocks Biotech Gold Oil Mining China Asian MENU
Biotech Gold Oil Mining China Asian
Find Tomorrow's Winners Today

Stock technical analysis
Rating Flag Rating Flag Rating Flag Rating Flag Rating Flag
sell neutral buy
IVERIC bio, Inc. (ISEE)
5.1  -0.06  (-1.16%) 07-03 14:48
Open: 5.25 High: 5.47
Pre.close: 5.16 Low: 5.045
Volume: 768,442 Ave vol: 1,037,484
52w High: 8.97 52w Low: 0.906
MA(50): 4.594 MA(200): 5.187
EPS: -1.358 P/E Ratio: 0
Company profile
Exchange: NASDAQ
Sector: Healthcare
Industry: Biotechnology
Website: http://ivericbio.com
Market Cap (M): 451
Shares Out (M): 88
IVERIC bio, Inc., a biopharmaceutical company, develops novel therapies to treat ophthalmic diseases with a focus on age-related and orphan retinal diseases. The company is developing Zimura, an inhibitor of complement factor C5, which is in Phase IIb clinical trials for the treatment of geographic atrophy (GA), a late-stage form of dry age-related macular degeneration (AMD) characterized by retinal cell death and degeneration of tissue in the central portion of the retina known as the macula; and autosomal recessive Stargardt disease (STGD1), which is an orphan inherited retinal disease (IRD). It is also developing High temperature requirement A serine peptidase 1 protein (HtrA1) inhibitors for the treatment of GA secondary to dry AMD and other age-related retinal diseases, such as wet AMD and idiopathic polypoidal choroidal vasculopathy.
Technical analysis
Overall: Underperform
MA: Bullish MACD: Bullish
KDJ: Bearish RSI: Bearish
Target 1: 7.94 Target 2: 9.28
Resist 1: 6.80 Resist 2: 7.94
Support 1: 4.90 Support 2: 3.72
Company key metrics
Revenue per Share: 0
Net Income per Share: -1.394
Cash per Share: 2.977
Book Value per Share: 2.7757
Price to Sales: 0
Price to Book Value: 2.403
Earnings Yield: -0.209
Dividend Yield: 0
Debt to Equity: 0.1108
Debt to Assets: 0.0997
Financial analysis
Price to Book Value: Outperform
Return on Assets: Underperform
Return on Equity: Underperform
Discounted cash flow: Outperform
Price to Earnings: Underperform
Debt to Equity: Neutral
Stock Charts
Headline news
Tue, 16 Jun 2020
Is IVERIC bio, Inc. (ISEE) Going to Burn These Hedge Funds? - Yahoo Finance

Fri, 03 Jul 2020
Moving Average Crossover Alert: IVERIC bio - Yahoo Finance

Tue, 30 Jun 2020
IVERIC bio Announces First Patient Dosed in Second Zimura¬ģ Phase 3 Clinical Trial for the Treatment of Geographic Atrophy Secondary to Age-Related Macular Degeneration - Business Wire

Thu, 18 Jun 2020
Why Iveric Bio Is Skyrocketing 24% Today - The Motley Fool

Mon, 15 Jun 2020
Why Shares of Micro-Cap Biopharma IVERIC Bio Are Ripping Higher - Benzinga

Tue, 30 Jun 2020
Analyzing Future Direction of IVERIC bio, Inc. (ISEE): Next Earning Report on 07/29/2020 - The News Heater

HonorStocks, Find Tomorrow's Winners Today

©HonorStocks.com | U.S. stock markets, stock quotes and stock analysis. Data and information is provided for informational purposes only, is not intended for trading purposes and is not investment advice. Neither HonorStocks.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Market data provided by: IEX and Financial Modeling Prep

Privacy Policy: Third parties, including Google, may be placing and reading cookies on your browsers, or other methods to collect information as a result of ad serving on this website. Google's use of advertising cookies enables it and its partners to serve ads to you based on your visit to this site and/or other sites on the Internet. You may opt out of personalized advertising by visiting Ads Settings. If you choose to use this website, you agree to the collection and use of information in relation to this policy. The information collected is used for providing and improving the ads Service. We will not use or share information with anyone, and we do not store any data from users.